Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)
Titel:
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)
Auteur:
Heeney, Matthew M. Abboud, Miguel R. Amilon, Carl Andersson, Marielle Githanga, Jessie Inusa, Baba Kanter, Julie Leonsson-Zachrisson, Maria Michelson, Alan D. Berggren, Anders R.